These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3140546)

  • 1. [Comparative study of murine B-cells obtained by 2 different methods proliferating long-term in vitro].
    Volgareva GM; Vlasov GS; Kil'diushevskaia TV; Zvenigorodskaia VP
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jun; (6):80-4. PubMed ID: 3140546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Culture conditions that optimize outgrowth of hybridomas.
    Hamilton MJ; Davis WC
    Methods Mol Biol; 1995; 45():17-28. PubMed ID: 7550679
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cultivation of murine B-cell hybridomas in the spleen].
    Volgareva GM; Kil'diushevskaia TV; Del'vig AA; Kozhevnikova EV; Sviridov VV
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jan; (1):94-8. PubMed ID: 3551420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of myelopeptides on DNA and protein synthesis and antibody secretion by mouse B-cell hybridomas].
    Novikov VI; Sorokin SV; Mikhaĭlova AA
    Biull Eksp Biol Med; 1989 Jun; 107(6):724-6. PubMed ID: 2790173
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of stable heterohybridomas producing human monoclonal antibodies.
    Cooper MD; Kirkpatrick R
    Methods Mol Biol; 1995; 45():29-39. PubMed ID: 7550689
    [No Abstract]   [Full Text] [Related]  

  • 6. Facilitated cell fusion for hybridoma production.
    Conrad MK; Lo MM
    Methods Enzymol; 1990; 184():641-53. PubMed ID: 2167431
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monoclonal antibodies from the hybridization of lymphocytes].
    Ax W
    Ric Clin Lab; 1983; 13 Suppl 2():1-9. PubMed ID: 6366991
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of formation of murine B-hybridomas by using various polyethylene glycols].
    Paniutich AV
    Gematol Transfuziol; 1988 Dec; 33(12):47-51. PubMed ID: 3266167
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of Bcl-2/B cell transgenic mice (B6) for hybridoma production.
    Knott CL; Reed JC; Bodrug S; Saedi MS; Kumar A; Kuus-Reichel K
    Hybridoma; 1996 Oct; 15(5):365-71. PubMed ID: 8913786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of monoclonal antibodies against Neisseria meningitidis using popliteal lymph nodes and in vivo/in vitro immunization: prevalence study of new monoclonal antibodies in greater São Paulo, Brazil.
    Belo EF; Ferraz AS; Coutinho LM; Oliveira AP; Carmo AM; Tunes CF; Ferreira T; Ito AY; Machado MS; De L Franco D; De Gaspari EN
    Hybridoma (Larchmt); 2007 Oct; 26(5):302-10. PubMed ID: 17979546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of monoclonal antibodies specific for African swine fever virus following in vitro primary immunization of mouse splenocytes in the presence of stimulated T lymphocyte supernatants.
    Federspiel G; McCullough KC; Kihm U
    J Immunol Methods; 1991 Dec; 145(1-2):71-81. PubMed ID: 1765668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colcemid treatment of myeloma prior to cell fusion increases the yield of hybridomas between myeloma and splenocyte.
    Miyahara M; Nakamura H; Hamaguchi Y
    Biochem Biophys Res Commun; 1984 Nov; 124(3):903-8. PubMed ID: 6508785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of proliferation of a murine myeloma cell line and mitogen-stimulated B lymphocytes by the antibiotic amphotericin B (Fungizone).
    Walls EV; Kay JE
    Immunology; 1982 Sep; 47(1):115-21. PubMed ID: 6981585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of IgG-producing hybridomas by in vitro stimulation of murine spleen cells.
    Takahashi M; Fuller SA; Hurrell JG
    J Immunol Methods; 1987 Feb; 96(2):247-53. PubMed ID: 3492563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a serum-free medium for growth of NS-1 mouse myeloma cells and its application to the isolation of NS-1 hybridomas.
    Kawamoto T; Sato JD; Le A; McClure DB; Sato GH
    Anal Biochem; 1983 Apr; 130(2):445-53. PubMed ID: 6869833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of an anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation.
    Rycyzyn MA; Staquet K; Fisher J; Bannish G; Bassiri A; Duchala C; Giles-Komar J
    Hybridoma (Larchmt); 2008 Feb; 27(1):25-30. PubMed ID: 18294073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies to establish human monoclonal antibodies.
    Kudo T; Saeki H; Saijyo S; Sato N; Numasaki M; Tachibana T
    Tohoku J Exp Med; 1992 Oct; 168(2):323-7. PubMed ID: 1306317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies: methods and clinical laboratory applications.
    Nakamura RM
    Clin Physiol Biochem; 1983; 1(2-5):160-72. PubMed ID: 6396016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Persistent expression of DNA.
    Velikovsky CA; Cassataro J; Sanchez M; Fossati CA; Fainboim L; Spitz M
    J Immunol Methods; 2000 Oct; 244(1-2):1-7. PubMed ID: 11033013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.